Predictions for the Global Life Sciences Industry, 2020 – Sustainable Pricing Models Will Encourage Stronger, New Product Pipelines

Dublin, Feb. 18, 2020 (GLOBE NEWSWIRE) — The “Predictions for the Global Life Sciences Industry, 2020” report has been added to ResearchAndMarkets.com’s offering.The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics.This study explores specific technologies that are expected to have the largest impact across the drug lifecycle.This study explores more specific tangents of connected and intelligent bioprocessing and highlights the key companies that are enabling this change.This research service provides insights into the reimbursement models which will change the course of business strategies for pharma companies and associated stakeholders and ensure sustainable growth in the segment.
With a large number of innovations in diagnostics coming from global IVD players, local companies in the APAC region are using multilateral collaborations to facilitate early introduction of innovations in local markets as well as shaping portfolio choices to bridge gaps in high growth but under-served markets.Lastly, the study highlights the convergence of pharmaceuticals, new diagnostic technologies, and unavoidable need for companion diagnostics, which has been enabled by the regulatory and commercial evolution in the global life sciences industry.Key Topics Covered
1. Executive SummaryScopeKey Questions this Study Will AnswerPharma and BiotechSegment Snapshot – Pharma and BiotechIVD and Research ToolsSegment Snapshot – IVD and Research Tools2. Life Sciences – Predictions for 2020Prediction 1 – Artificial Intelligence to Witness Accelerated Adoption in Drug Discovery Innovation in Cancer and Rare DiseasesKey Implications for StakeholdersKey Companies to Watch in 2020Prediction 2 – Microbiome-based Cancer Therapy to Witness Densest Clinical Pipeline and Capital InfluxKey Implications for StakeholdersKey Companies to Watch in 2020Prediction 3 – Connected and Intelligent Bioprocessing to Improve Biologic Manufacturing ProductivityKey Implications for StakeholdersKey Companies to Watch in 2020Prediction 4 – Genome Sequencing Initiatives to Trigger Precision Medicine IVD in JapanKey Implications for StakeholdersKey Companies to Watch in 2020Prediction 5 – Annuity-based Model to Catapult Gene Therapy Commercialization in Regulated MarketsKey Implications for StakeholdersKey Companies to Watch in 20203. Growth Opportunities and Companies to ActionStrategic Imperatives for Life Sciences Companies4. Last WordImpact of Technology on LS Stakeholders5. AppendixGeographical TrendsAbbreviationsList of ExhibitsFor more information about this report visit https://www.researchandmarkets.com/r/nbqkdResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900